Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Littlewood

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Plos Neglected Tropical Diseases|July 15, 2016
Sustaining Progress towards NTD Elimination: An Opportunity to Leverage Lymphatic Filariasis Elimination Programs to Interrupt Transmission of Soil-Transmitted HelminthsArianna Rubin Means, Kristjana Ásbjörnsdóttir, Charles Mwandawiro, et al.
Circulation|March 16, 2011
Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imagingThomas J Cahill, Oni Chowdhury, Saul G Myerson, et al.
Current Medical Research and Opinion|May 11, 2006
Iron and the anaemia of chronic disease: a review and strategic recommendationsIvor Cavill, Michael Auerbach, George R Bailie, et al.
Blood|July 22, 2006
A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapySteven Knapper, Alan K Burnett, Tim Littlewood, et al.
International Journal of Hematology|September 8, 2011
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplantPatrick Medd, Ian Monk, Robert Danby, et al.
Transfusion Medicine Reviews|July 27, 2010
Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusionsSimon J Stanworth, Claire Dyer, Louise Choo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2006
Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Jean-Michel Boiron, et al.
British Journal of Haematology|June 22, 2011
Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromesNoémi B A Roy, Saul Myerson, Anna H Schuh, et al.
Blood|November 24, 2012
Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemiaToby Eyre, Claire J Schwab, Ross Kinstrie, et al.
Blood|August 4, 2005
Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeAlexander Sternberg, Sally Killick, Tim Littlewood, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos Neglected Tropical Diseases|July 15, 2016
Sustaining Progress towards NTD Elimination: An Opportunity to Leverage Lymphatic Filariasis Elimination Programs to Interrupt Transmission of Soil-Transmitted HelminthsArianna Rubin Means, Kristjana Ásbjörnsdóttir, Charles Mwandawiro, et al.
Circulation|March 16, 2011
Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imagingThomas J Cahill, Oni Chowdhury, Saul G Myerson, et al.
Current Medical Research and Opinion|May 11, 2006
Iron and the anaemia of chronic disease: a review and strategic recommendationsIvor Cavill, Michael Auerbach, George R Bailie, et al.
Blood|July 22, 2006
A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapySteven Knapper, Alan K Burnett, Tim Littlewood, et al.
International Journal of Hematology|September 8, 2011
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplantPatrick Medd, Ian Monk, Robert Danby, et al.
Transfusion Medicine Reviews|July 27, 2010
Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusionsSimon J Stanworth, Claire Dyer, Louise Choo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2006
Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Jean-Michel Boiron, et al.
British Journal of Haematology|June 22, 2011
Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromesNoémi B A Roy, Saul Myerson, Anna H Schuh, et al.
Blood|November 24, 2012
Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemiaToby Eyre, Claire J Schwab, Ross Kinstrie, et al.
Blood|August 4, 2005
Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeAlexander Sternberg, Sally Killick, Tim Littlewood, et al.
Pageof 3